Literature DB >> 18657195

Endogenous DNA damage and testicular germ cell tumors.

M B Cook1, A J Sigurdson, I M Jones, C B Thomas, B I Graubard, L Korde, M H Greene, K A McGlynn.   

Abstract

Testicular germ cell tumors are comprised of two histologic groups, seminomas and non-seminomas. We postulated that the possible divergent pathogeneses of these histologies may be partially explained by variable levels of net endogenous DNA damage. To test our hypothesis, we conducted a case-case analysis of 51 seminoma and 61 non-seminoma patients using data and specimens from the Familial Testicular Cancer study and the U.S. Radiologic Technologists cohort. A lymphoblastoid cell line was cultured for each patient and the alkaline comet assay was used to determine four parameters: tail DNA, tail length, comet distributed moment (CDM) and Olive tail moment (OTM). Odds ratios (OR) and 95% confidence intervals (95% CI) were estimated using logistic regression. Values for tail length, tail DNA, CDM and OTM were modelled as categorical variables using the 50th and 75th percentiles of the seminoma group. Tail DNA was significantly associated with non-seminoma compared with seminoma (OR(50th percentile) = 3.31, 95% CI: 1.00, 10.98; OR(75th percentile) = 3.71, 95% CI: 1.04, 13.20; p for trend = 0.039). OTM exhibited similar, albeit statistically non-significant, risk estimates (OR(50th percentile) = 2.27, 95% CI: 0.75, 6.87; OR(75th percentile) = 2.40, 95% CI: 0.75, 7.71; p for trend = 0.12) whereas tail length and CDM showed no association. In conclusion, the results for tail DNA and OTM indicate that net endogenous levels are higher in patients who develop non-seminoma compared with seminoma. This may partly explain the more aggressive biology and younger age-of-onset of this histologic subgroup compared with the relatively less aggressive, later-onset seminoma.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18657195      PMCID: PMC2874631          DOI: 10.1111/j.1365-2605.2008.00905.x

Source DB:  PubMed          Journal:  Int J Androl        ISSN: 0105-6263


  56 in total

Review 1.  Genetic polymorphism and cancer risk.

Authors:  M L Clapper
Journal:  Curr Oncol Rep       Date:  2000-05       Impact factor: 5.075

2.  Current views on the pathogenesis of testicular germ cell tumours and perspectives for future research: highlights of the 5th Copenhagen Workshop on Carcinoma in situ and Cancer of the Testis.

Authors:  J Wolter Oosterhuis; Leendert H J Looijenga
Journal:  APMIS       Date:  2003-01       Impact factor: 3.205

3.  Genetic instability in bladder cancer assessed by the comet assay.

Authors:  Matthew B Schabath; Margaret R Spitz; H Barton Grossman; Kerang Zhang; Colin P Dinney; Ping-Ju Zheng; Xifeng Wu
Journal:  J Natl Cancer Inst       Date:  2003-04-02       Impact factor: 13.506

4.  Sister chromatid exchange rate and alkaline comet assay scores in patients with ovarian cancer.

Authors:  Volkan Baltaci; Fulya Kayikçioğlu; Idil Alpas; Hulusi Zeyneloğlu; Ali Haberal
Journal:  Gynecol Oncol       Date:  2002-01       Impact factor: 5.482

5.  Pre-natal and peri-natal exposures and risk of testicular germ-cell cancer.

Authors:  H K Weir; L D Marrett; N Kreiger; G A Darlington; L Sugar
Journal:  Int J Cancer       Date:  2000-08-01       Impact factor: 7.396

Review 6.  Increasing incidence of testicular cancer worldwide: a review.

Authors:  Eric Huyghe; Tomohiro Matsuda; Patrick Thonneau
Journal:  J Urol       Date:  2003-07       Impact factor: 7.450

7.  Parental and birth characteristics in relation to testicular cancer risk among males born between 1960 and 1995 in California (United States).

Authors:  Paul B English; Debbie E Goldberg; Craig Wolff; Daniel Smith
Journal:  Cancer Causes Control       Date:  2003-11       Impact factor: 2.506

8.  DNA damage and breast cancer risk.

Authors:  Tasha R Smith; Mark S Miller; Kurt K Lohman; L Douglas Case; Jennifer J Hu
Journal:  Carcinogenesis       Date:  2003-05       Impact factor: 4.944

9.  Trends in the incidence of testicular germ cell tumors in the United States.

Authors:  Katherine A McGlynn; Susan S Devesa; Alice J Sigurdson; Linda M Brown; Lilian Tsao; Robert E Tarone
Journal:  Cancer       Date:  2003-01-01       Impact factor: 6.860

10.  Perinatal determinants of germ-cell testicular cancer in relation to histological subtypes.

Authors:  L Richiardi; O Akre; R Bellocco; A Ekbom
Journal:  Br J Cancer       Date:  2002-08-27       Impact factor: 7.640

View more
  2 in total

Review 1.  Familial testicular germ cell tumors in adults: 2010 summary of genetic risk factors and clinical phenotype.

Authors:  Mark H Greene; Christian P Kratz; Phuong L Mai; Christine Mueller; June A Peters; Gennady Bratslavsky; Alex Ling; Peter M Choyke; Ahalya Premkumar; Janet Bracci; Rissah J Watkins; Mary Lou McMaster; Larissa A Korde
Journal:  Endocr Relat Cancer       Date:  2010-03-08       Impact factor: 5.678

2.  The prognostic value of DNA damage level in peripheral blood lymphocytes of chemotherapy-naïve patients with germ cell cancer.

Authors:  Zuzana Sestakova; Katarina Kalavska; Lenka Hurbanova; Dana Jurkovicova; Jan Gursky; Michal Chovanec; Daniela Svetlovska; Vera Miskovska; Jana Obertova; Patrik Palacka; Katarina Rejlekova; Zuzana Sycova-Mila; Silvia Cingelova; Stanislav Spanik; Jozef Mardiak; Miroslav Chovanec; Michal Mego
Journal:  Oncotarget       Date:  2016-11-15
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.